UroGen Pharma Strengthens Board of Directors and Senior Management Team
Feb 09, 2016 13:00 pm UTC| Business
NEW YORK and RA’ANANA, Israel, Feb. 09, 2016 -- UroGen Pharma, Ltd. a clinical-stage biopharmaceutical company developing novel, locally-administered pharmaceutical solutions for urological pathologies with a focus on...
Ambarella Announces Q4 and FY 2016 Earnings Conference Call to be Held March 3, 2016
Feb 09, 2016 13:00 pm UTC| Business
SANTA CLARA, Calif., Feb. 09, 2016 -- Ambarella, Inc., (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video processing semiconductors, today announced that it will hold its Q4 FY 2016 conference call...
Motorcar Parts of America Reports Fiscal 2016 Third Quarter and Nine-Month Results
Feb 09, 2016 13:00 pm UTC| Business
LOS ANGELES, Feb. 09, 2016 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today reported results for its fiscal 2016 third quarter and nine months – reflecting record sales and profitability for a quarter, supported...
Westlake Chemical Corporation Announces Fourth Quarter 2015 Earnings Conference Call
Feb 09, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 09, 2016 -- Westlake Chemical Corporation (NYSE:WLK) will release its 2015 fourth quarter earnings prior to the market opening on Tuesday, February 23, 2016. The company will host a conference call at...
BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product
Feb 09, 2016 13:00 pm UTC| Business
MELVILLE, N.Y., Feb. 09, 2016 -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that it is implementing a numeric...
Feb 09, 2016 13:00 pm UTC| Business
BOTHELL, Wash., Feb. 09, 2016 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the prevention of migraine, Cushing's disease,...
Feb 09, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 09, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (“Freeport” or the “Company”) (NYSE:FCX) and certain of its officers. The class action, filed...